Qube Research & Technologies LTD Haemonetics Corp Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Haemonetics Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 43,122 shares of HAE stock, worth $3.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,122
Holding current value
$3.24 Million
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$81.24 - $97.37 $3.5 Million - $4.2 Million
43,122 New
43,122 $3.57 Million
Q4 2023

Feb 13, 2024
BUY
$80.59 - $92.61 $3.43 Million - $3.94 Million
42,589 Added 76051.79%
42,645 $3.65 Million
Q3 2023

Nov 13, 2023
SELL
$82.56 - $93.49 $1.09 Million - $1.24 Million
-13,253 Reduced 99.58%
56 $5,000
Q2 2023

Aug 14, 2023
SELL
$80.84 - $89.45 $194,581 - $215,306
-2,407 Reduced 15.32%
13,309 $1.13 Million
Q1 2023

May 15, 2023
SELL
$72.75 - $90.6 $1.74 Million - $2.17 Million
-23,897 Reduced 60.33%
15,716 $1.3 Million
Q4 2022

Feb 14, 2023
BUY
$73.85 - $86.14 $1.13 Million - $1.32 Million
15,278 Added 62.78%
39,613 $3.12 Million
Q3 2022

Nov 14, 2022
BUY
$63.3 - $78.66 $42,094 - $52,308
665 Added 2.81%
24,335 $1.8 Million
Q2 2022

Aug 15, 2022
BUY
$49.27 - $66.08 $1.17 Million - $1.56 Million
23,670 New
23,670 $1.54 Million
Q2 2021

Aug 13, 2021
SELL
$51.81 - $118.56 $1.34 Million - $3.06 Million
-25,827 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$111.01 - $139.48 $2.87 Million - $3.6 Million
25,827 New
25,827 $2.87 Million
Q3 2020

Nov 12, 2020
SELL
$75.65 - $93.58 $2.66 Million - $3.3 Million
-35,224 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$84.96 - $118.91 $2.99 Million - $4.19 Million
35,224 New
35,224 $3.16 Million
Q1 2020

May 15, 2020
SELL
$74.34 - $121.82 $145,260 - $238,036
-1,954 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$114.37 - $129.46 $223,478 - $252,964
1,954 New
1,954 $225,000
Q3 2019

Nov 13, 2019
SELL
$117.16 - $138.52 $250,136 - $295,740
-2,135 Closed
0 $0
Q2 2019

Aug 02, 2019
BUY
$81.74 - $120.34 $174,514 - $256,925
2,135 New
2,135 $257,000
Q4 2018

Feb 14, 2019
SELL
$90.66 - $116.63 $157,295 - $202,353
-1,735 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$89.96 - $114.58 $116,408 - $148,266
1,294 Added 293.42%
1,735 $199,000
Q2 2018

Aug 14, 2018
BUY
$71.53 - $95.75 $31,544 - $42,225
441 New
441 $40,000

Others Institutions Holding HAE

# of Institutions
337
Shares Held
55.2M
Call Options Held
383K
Put Options Held
45.1K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.85B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email